• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Peptide dendrimers G3KL and TNS18 inhibit Pseudomonas aeruginosa biofilms
 

Peptide dendrimers G3KL and TNS18 inhibit Pseudomonas aeruginosa biofilms

Options
  • Details
  • Files
BORIS DOI
10.7892/boris.138468
Publisher DOI
10.1007/s00253-019-09801-3
PubMed ID
31101943
Description
Herein we report that peptide dendrimers G3KL and TNS18, which were recently reported to control multidrug-resistant bacteria such as Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii, strongly inhibit biofilm formation by P. aeruginosa PA14 below their minimum inhibitory concentration (MIC) value, under which conditions they also strongly affect swarming motility. Eradication of preformed biofilms, however, required concentrations above the MIC values. Scanning electron microscopy observation and confocal laser scanning micrographs showed that peptide dendrimers can destroy the biofilm morphological structure and thickness in a dose-dependent manner, even make the biofilm dispersed completely. Membrane potential analysis indicated that planktonic cells treated with peptide dendrimers presented an increase in fluorescence intensity, suggesting that cytoplasmic membrane could be the target of G3KL and TNS18 similarly to polymyxin B. RNA-seq analysis showed that the expressions of genes in the arnBCADTEF operon-regulating lipid A modification resulting in resistance to AMPs are differentially affected between these three compounds, suggesting that each compound targets the cell membrane but in different manner. Potent activity on planktonic cells and biofilms of P. aeruginosa suggests that peptide dendrimers G3KL and TNS18 are promising candidates of clinical development for treating infections.
Date of Publication
2019
Publication Type
Article
Subject(s)
500 Science > 570 Life sciences; biology
500 Science > 540 Chemistry
Language(s)
en
Contributor(s)
Han, Xiao
Liu, Yujie
Ma, Yibing
Zhang, Mengqing
He, Zhengjin
Siriwardena, Thissa Appuhamilage
Departement für Chemie und Biochemie (DCB)
Xu, Haijin
Bai, Yanling
Zhang, Xiuming
Reymond, Jean-Louisorcid-logo
Departement für Chemie und Biochemie (DCB)
Qiao, Mingqiang
Additional Credits
Departement für Chemie und Biochemie (DCB)
Series
Applied microbiology and biotechnology
Publisher
Springer
ISSN
0175-7598
Access(Rights)
open.access
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo